HIV treatment outcomes among formerly incarcerated transitions clinic patients in a high prevalence setting

Health & Justice
Mariya I MasyukovaAaron D Fox

Abstract

Incarceration disproportionately affects people living with HIV/AIDS. When people are released from jail or prison, they face multiple barriers to HIV care, and those who do engage in care may have suboptimal HIV treatment outcomes. A limited number of studies have investigated HIV treatment outcomes among people who have been released from incarceration. We conducted a retrospective cohort study comparing HIV viral load (VL) suppression and retention in care 12 months after entry into care among patients of a post-incarceration Transitions Clinic (TC) and a comparison group who received HIV care in the same community. Of 138 participants, 38 TC patients were matched to 100 non-TC controls based on age, race/ethnicity, gender, and date of HIV care entry. There was no significant difference in clinical study outcomes between TC and non-TC patients: 63% vs. 67% (p = 0.67) were retained in care and 54% vs. 63% (p = 0.33) had suppressed VL at 12 months. After adjusting for substance use disorder and viral load suppression at the start of treatment, the odds ratio of TC patients' 12-month retention was 0.60 (95% CI 0.25-1.49) and VL suppression was 0.44 (95% CI 0.16-1.23) compared with non-TC patients. Our findings show HIV care out...Continue Reading

References

Jun 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·N Freudenberg
Jun 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·J D RichT Flanigan
Jul 1, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra A SpringerFrederick L Altice
Jul 2, 2004·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Cheryl L Cooke
Jul 6, 2004·Epidemiologic Reviews·K E PoundstoneD D Celentano
Nov 2, 2005·International Journal of Offender Therapy and Comparative Criminology·Mark M Lanier, Eugene A Paoline
May 13, 2008·Journal of Health Care for the Poor and Underserved·Nickolas D ZallerJosiah D Rich
Feb 27, 2009·JAMA : the Journal of the American Medical Association·Jacques BaillargeonDavid P Paar
Jun 23, 2010·AIDS Patient Care and STDs·Jacques BaillargeonDavid P Paar
Nov 4, 2010·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Amy NunnCurt Beckwith
Aug 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sandra A SpringerFrederick L Altice
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ryan P WestergaardShruti H Mehta
Oct 2, 2012·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Thana KhawcharoenpornHarold A Kessler
Oct 30, 2012·AIDS and Behavior·Anne C SpauldingPaula M Frew
Nov 20, 2012·AIDS and Behavior·Amy L AlthoffFrederick L Altice
Dec 12, 2012·Current Opinion in Infectious Diseases·Ryan P WestergaardTimothy P Flanigan
Mar 5, 2013·AIDS and Behavior·Adrian LiauUNKNOWN HIV/AIDS Prevention Research Synthesis (PRS) Team
Jan 18, 2014·American Journal of Public Health·Jaimie P MeyerFrederick L Altice
May 15, 2015·American Journal of Public Health·Princess A IrohAnk E Nijhawan
Jul 21, 2015·The Journal of the Association of Nurses in AIDS Care : JANAC·Alexis C DennisCarol E Golin
Nov 26, 2015·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Natalie BrackenNina T Harawa
Mar 10, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David A WohlPatrick M Flynn
Dec 2, 2017·The Lancet. HIV·David Alain Wohl, David Loren Rosen

❮ Previous
Next ❯

Citations

Sep 17, 2019·JAMA Internal Medicine·Lawrence A HaberLisa A Pratt
Aug 13, 2020·Infectious Disease Clinics of North America·Daniel WinetskyJosiah D Rich

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Urban Health : Bulletin of the New York Academy of Medicine
Michael CostaJosiah D Rich
Journal of Health Care for the Poor and Underserved
Aaron D FoxChinazo O Cunningham
Journal of the International Association of Providers of AIDS Care
Kristen L BunnellMelissa Badowski
© 2022 Meta ULC. All rights reserved